Amedisys Inc (AMED): Price and Financial Metrics


Amedisys Inc (AMED)

Today's Latest Price: $207.77 USD

2.93 (1.43%)

Updated Jul 10 6:55pm

Add AMED to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 67 in Medical - Services

See all "A" rated Strong Buy stocks

AMED Stock Summary

  • With a one year PEG ratio of 910.71, Amedisys Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.79% of US stocks.
  • The price/operating cash flow metric for Amedisys Inc is higher than 89.91% of stocks in our set with a positive cash flow.
  • The volatility of Amedisys Inc's share price is greater than that of merely 14.06% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to AMED, based on their financial statements, market capitalization, and price volatility, are EHC, ATR, LXFR, WD, and PRI.
  • Visit AMED's SEC page to see the company's official filings. To visit the company's web site, go to www.amedisys.com.
AMED Daily Price Range
AMED 52-Week Price Range

AMED Stock Price Chart Technical Analysis Charts


AMED Price/Volume Stats

Current price $207.77 52-week high $218.44
Prev. close $204.84 52-week low $120.77
Day low $196.96 Volume 246,300
Day high $208.38 Avg. volume 334,511
50-day MA $187.66 Dividend yield N/A
200-day MA $171.27 Market Cap 6.73B

Amedisys Inc (AMED) Company Bio


Amedisys provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The company was founded in 1982 and is based in Baton Rouge, Louisiana.

AMED Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$207.77$132-36%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Amedisys Inc. To summarize, we found that Amedisys Inc ranked in the 37th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Amedisys Inc, consider:

  • The business' balance sheet suggests that 6% of the company's capital is sourced from debt; this is greater than only 16.49% of the free cash flow producing stocks we're observing.
  • AMED's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 45.32% of tickers in our DCF set.
  • As a business, Amedisys Inc experienced a tax rate of about 18% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 80.27% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-38%
1%-37%
2%-36%
3%-36%
4%-35%
5%-35%

Want more companies with a valuation profile/forecast similar to that of Amedisys Inc? See STAA, ENDP, JNJ, GSK, and PDEX.


AMED Latest News Stream


Event/TimeNews Detail
Loading, please wait...

AMED Latest Social Stream


Loading social stream, please wait...

View Full AMED Social Stream

Latest AMED News From Around the Web

Below are the latest news stories about Amedisys Inc that investors may wish to consider to help them evaluate AMED as an investment opportunity.

Why Biotechs Are Moving Up Among 4 Top-Rated Health Care Stocks

The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

Yahoo | July 10, 2020

ADUS vs. AMED: Which Stock Is the Better Value Option?

ADUS vs. AMED: Which Stock Is the Better Value Option?

Yahoo | July 9, 2020

Amedisys Rides on Hospice Arm Expansion Amid Coronavirus Woes

Amedisys (AMED) benefits from the recent acquisitions of hospice care providers, Asana Hospice, RoseRock Healthcare and Compassionate Care Hospice.

Yahoo | June 23, 2020

Should You Avoid Amedisys Inc (AMED)?

In this article you are going to find out whether hedge funds think Amedisys Inc (NASDAQ:AMED) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the

Yahoo Finance | June 19, 2020

DGX vs. AMED: Which Stock Is the Better Value Option?

DGX vs. AMED: Which Stock Is the Better Value Option?

Yahoo | June 18, 2020

Read More 'AMED' Stories Here

AMED Price Returns

1-mo 22.24%
3-mo 4.45%
6-mo 17.58%
1-year 68.92%
3-year 249.96%
5-year 389.45%
YTD 24.47%
2019 42.53%
2018 122.18%
2017 23.65%
2016 8.42%
2015 33.97%

Continue Researching AMED

Here are a few links from around the web to help you further your research on Amedisys Inc's stock as an investment opportunity:

Amedisys Inc (AMED) Stock Price | Nasdaq
Amedisys Inc (AMED) Stock Quote, History and News - Yahoo Finance
Amedisys Inc (AMED) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0237 seconds.